Siga Technologies INC Other Non-Current Liabilities
Siga Technologies INC (SIGA) had Other Non-Current Liabilities of $2.60 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $2.60M.
- 2026-03-31: Other Liabilities, Noncurrent $2.61M.
- 2025-12-31: Other Liabilities, Noncurrent $2.65M.
- 2025-09-30: Other Liabilities, Noncurrent $3.28M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.61M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.65M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $3.28M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $3.30M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $3.13M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.20M 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |